Haemato Oncology

Overview

What is Haemato-Oncology?

Sitting at the intersection of haematology, hemato-oncology is broken into two. Haematology is the study of blood, and oncology is the study of cancer. Its main focus is specifically on cancers that arise from blood-forming tissues. These could be the bone marrow, lymph nodes and spleen. Blood cancers do not form a single lump that can be removed with surgery, which is different to solid tumours. As they circulate throughout the body, their treatment and diagnosis may sometimes be uniquely challenging.

A hemato-oncologist manages these conditions that tend to be complex. Understanding how cancer grows, they also know how it disrupts the normal production of blood cells like the red cells that carry oxygen, white cells that fight infection and platelets that control bleeding. Many patients arrive at a hemato-oncology clinic feeling exhausted. They bruise easily or are dealing with repeated infections that will not go away. The role of the specialist is critical because these vague symptoms often get dismissed at first.

Types of Blood Cancers

Blood cancers fall into three main categories, with each one behaving quite differently.

Leukaemia is a cancer of the white blood cells and starts in the bone marrow. It tends to progress quickly in its acute forms. It floods the bloodstream with immature, non-functioning cells. Lymphoma affects the lymphatic system, which is part of the body's immune defence. Patients often notice swollen lymph nodes in the neck, armpit or groin that do not go away. Myeloma begins in plasma cells, another type of immune cell, and can cause bone pain, kidney problems and recurrent infections.

Hemato-oncology also covers other issues, beyond cancer. It treats myelodysplastic syndromes, which is where the bone marrow produces faulty blood cells. Myeloproliferative disorders, where the marrow produces too many cells, are also treated alongside aplastic anaemia, where it produces too few cells. Each condition requires a different approach as it has its own path.

Blood cancer symptoms overlap with many common, harmless conditions. Seeking help may not always be straightforward, but certain patterns should prompt a visit to a doctor.

"B symptoms" is the term given to unexplained weight loss, drenching night sweats that soak through pyjamas and persistent fevers without an obvious infection. These can be red flags for lymphoma or leukaemia. Extreme fatigue is another sign, albeit vague. It is usually the type that does not improve with rest and makes climbing a flight of stairs feel impossible.

A few things can indicate low platelets. These are easy bruising or bleeding that takes a long time to stop, tiny red spots on the skin (petechiae) or frequent nosebleeds. Frequent or severe infections might mean low white blood cells. Shortness of breath and looking unusually pale could signal anaemia from the bone marrow being crowded out by cancerous cells.

None of these symptoms guarantees a blood cancer. Most turn out to be something far less serious. Catching these conditions early makes a meaningful difference to outcomes, and a hemato-oncology clinic is where the proper investigations happen.

Diagnosis in hemato-oncology begins with a thorough consultation and physical examination. It pays close attention to lymph nodes, the spleen and any signs of bleeding or infection. The real answers always come from the lab.

The first step is always a full blood count. It measures the number of red cells, white cells and platelets in the blood. Abnormal patterns here raise suspicion, and they guide the next steps. A blood film, where a pathologist looks at the cells under a microscope, can sometimes spot leukaemia cells directly.

A bone marrow biopsy is usually required for a definitive diagnosis and using a local anaesthetic, a small sample of marrow is taken from the hip bone. This sounds more intimidating than it is and most patients have described it as uncomfortable rather than painful. The marrow sample is crucial as it reveals exactly what type of cells are growing abnormally. It also shows how aggressive they appear.

Further tests include immunophenotyping. This helps identify cells by their surface markers. Cytogenetics look for chromosome abnormalities. Molecular tests find specific gene mutations. These details matter enormously as they determine which treatments will work and which will not. Modern hemato-oncology relies on this precision because two patients with the same type of lymphoma might receive completely different therapies. This is based on their genetic profile.

  • Acute Leukaemias
  • Chronic Leukaemias
  • Hodgkin and Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Aplastic Anaemia
  • Amyloidosis

Over the past decade, treatment in hemato-oncology has changed dramatically. Chemotherapy once dominated, but we now have a much broader toolkit.

We use targeted therapy, which are drugs that attack specific abnormalities on cancer cells. This leaves healthy cells largely alone. Immunotherapy helps the patient's own immune system to recognise and destroy the cancer on its own. The best chance of cure for certain aggressive leukaemias and lymphomas is through high-dose chemotherapy followed by a stem cell transplant. This involves collecting healthy blood-forming cells either from the patient or a donor, which is then infused after the diseased marrow has been wiped out.

Every patient seen at our hemato-oncology clinic at NMC has a treatment plan designed around their specific diagnosis, genetic markers, age and overall health. We involve patients in every decision. We explain why one approach might suit them better than another. So nothing falls through the cracks, our team coordinates closely with blood bank services, diagnostic labs and transplant specialists.

Our team at NMC includes consultant haematologists and medical oncologists bringing experience from major international centres, having dealt with cases from the most aggressive leukaemias to indolent lymphomas that may never need active treatment.

Setting them apart is how they communicate, operating with empathy and an understanding that biopsies and a potential leukaemia diagnosis land heavily. They answer every question and ensure families understand what comes next. They are comfortable with complexity and are meticulous about details. Having managed people for years or even decades with chronic conditions, they are deeply committed to their patients.

Our specialists offer the same standard of care at every NMC facility for anyone searching for a hemato-oncology clinic across the UAE in Abu Dhabi, Dubai, Sharjah, Ajman, Ras Al Khaimah and Al Ain. From fear to clarity, and from diagnosis to the best possible outcome, they are here to guide patients.

FAQs

Find the Answer to Your Medical Questions

Frequently Asked Questions

A general haematologist manages blood disorders that are benign. These could be anaemia, haemophilia and clotting problems. A hemato-oncologist is a specialist who focuses specifically on blood cancers. These are leukaemia, lymphoma and myeloma. They are also trained in cancer treatments like chemotherapy, immunotherapy and stem cell transplantation.
The sharp pain is brief because the procedure is done under local anaesthetic. Most patients feel pressure and a pulling sensation only during the sample collection. This is followed by a few days of soreness in the hip area, which is usually uncomfortable but very manageable. The information it provides is invaluable.
Many can, yes. There are very high cure rates for certain types of lymphoma and childhood leukaemia. Some chronic conditions, like myeloma, are not yet curable. They can, however, be controlled for many years with a good quality of life. With newer targeted therapies and immunotherapies, outcomes of blood cancers have significantly improved.
Location

NMC Footprints

0 Results found

Loading......